These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 8592127)
1. In vivo electrochemical studies of dopamine overflow and clearance in the striatum of normal and MPTP-treated rhesus monkeys. Gerhardt GA; Cass WA; Hudson J; Henson M; Zhang Z; Ovadia A; Hoffer BJ; Gash DM J Neurochem; 1996 Feb; 66(2):579-88. PubMed ID: 8592127 [TBL] [Abstract][Full Text] [Related]
2. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys. Gerhardt GA; Cass WA; Huettl P; Brock S; Zhang Z; Gash DM Brain Res; 1999 Jan; 817(1-2):163-71. PubMed ID: 9889359 [TBL] [Abstract][Full Text] [Related]
3. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626 [TBL] [Abstract][Full Text] [Related]
4. Increased dopamine clearance in the non-lesioned striatum of rhesus monkeys with unilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) striatal lesions. Cass WA; Gerhardt GA; Zhang Z; Ovadia A; Gash DM Neurosci Lett; 1995 Feb; 185(1):52-5. PubMed ID: 7731554 [TBL] [Abstract][Full Text] [Related]
5. In vivo changes of catecholamines in hemiparkinsonian monkeys measured by microdialysis. Skirboll S; Wang J; Mefford I; Hsiao J; Bankiewicz KS Exp Neurol; 1990 Nov; 110(2):187-93. PubMed ID: 1699780 [TBL] [Abstract][Full Text] [Related]
6. The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey. Irwin I; DeLanney LE; Forno LS; Finnegan KT; Di Monte DA; Langston JW Brain Res; 1990 Oct; 531(1-2):242-52. PubMed ID: 1981162 [TBL] [Abstract][Full Text] [Related]
7. Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys. Pifl C; Hornykiewicz O Neurochem Int; 2006 Oct; 49(5):519-24. PubMed ID: 16698121 [TBL] [Abstract][Full Text] [Related]
8. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Sirinathsinghji DJ; Whittington PE; Audsley AR Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361 [TBL] [Abstract][Full Text] [Related]
9. Age-related changes in potassium-evoked overflow of dopamine in the striatum of the rhesus monkey. Gerhardt GA; Cass WA; Henson M; Zhang Z; Ovadia A; Hoffer BJ; Gash DM Neurobiol Aging; 1995; 16(6):939-46. PubMed ID: 8622785 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterisation of dopamine overflow in the striatum of the normal and MPTP-treated common marmoset, studied in vivo using fast cyclic voltammetry, nomifensine and sulpiride. Earl CD; Sautter J; Xie J; Kruk ZL; Kupsch A; Oertel WH J Neurosci Methods; 1998 Dec; 85(2):201-9. PubMed ID: 9874156 [TBL] [Abstract][Full Text] [Related]
11. The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease. Pifl C; Schingnitz G; Hornykiewicz O Neurosci Lett; 1988 Oct; 92(2):228-33. PubMed ID: 3263594 [TBL] [Abstract][Full Text] [Related]
12. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys. Rioux L; Frohna PA; Joyce JN; Schneider JS Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972 [TBL] [Abstract][Full Text] [Related]
13. Increased dopamine turnover in the putamen after MPTP treatment in common marmosets. Nomoto M; Iwata SI; Kaseda S; Fukuda T; Nakagawa S Brain Res; 1997 Sep; 767(2):235-8. PubMed ID: 9367253 [TBL] [Abstract][Full Text] [Related]
14. MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration. Pérez-Otaño I; Oset C; Luquin MR; Herrero MT; Obeso JA; Del Río J Neurosci Lett; 1994 Jul; 175(1-2):121-5. PubMed ID: 7970192 [TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice. Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274 [TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice. D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368 [TBL] [Abstract][Full Text] [Related]
17. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Elsworth JD; Taylor JR; Sladek JR; Collier TJ; Redmond DE; Roth RH Neuroscience; 2000; 95(2):399-408. PubMed ID: 10658619 [TBL] [Abstract][Full Text] [Related]
18. Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted, MPTP-treated parkinsonian monkeys. Elsworth JD; Brittan MS; Taylor JR; Sladek JR; al-Tikriti MS; Zea-Ponce Y; Innis RB; Redmond DE; Roth RH Cell Transplant; 1996; 5(2):315-25. PubMed ID: 8689042 [TBL] [Abstract][Full Text] [Related]
19. Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study. Doudet DJ; Rosa-Neto P; Munk OL; Ruth TJ; Jivan S; Cumming P Neuroimage; 2006 Mar; 30(1):26-35. PubMed ID: 16378735 [TBL] [Abstract][Full Text] [Related]
20. Tremor is associated with PET measures of nigrostriatal dopamine function in MPTP-lesioned monkeys. Eberling JL; Pivirotto P; Bringas J; Bankiewicz KS Exp Neurol; 2000 Oct; 165(2):342-6. PubMed ID: 10993693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]